With 63% of UK adults being labelled either obese or overweight, weight management has never been so essential. Despite efforts to combat it through diet and exercise, many individuals struggle to achieve sustainable weight loss. Fortunately, recent advancements in medical science have led to the development of innovative treatments, including WeGovy weight loss injections.
WeGovy (Semaglutide) is a cutting-edge prescription medication approved by the FDA for chronic weight management in adults with obesity, or overweight individuals who have at least one weight-related condition. WeGovy works by replicating a natural hormone that regulates appetite. By curbing your appetite, it encourages reduced food intake, facilitating weight loss. For optimal results, WeGovy is best complemented with a controlled diet and regular exercise routine.
WeGovy is available in five different doses. You start with 0.25 mg once a week for the initial 4 weeks to allow your body to adjust. From Week 5, the dose increases to 0.5 mg weekly, then to 1.0 mg, and if necessary, to 1.7 mg and eventually 2.4 mg. Once you reach 2.4 mg, you maintain this dosage for the rest of your treatment.
The weekly weight loss jab is suitable for those who are over the age of 18 and with a BMI above 30 (or 27 with a weight related comorbidity).
Semaglutide will not be suitable and will not be prescribed if you fall into one of the categories below:
Clinical trials indicate that when used alongside diet, physical activity, and behavioural support, WeGovy users can achieve up to a 15% reduction in body weight after one year.
Wegovy and Saxenda are distinct weight loss injections, differing in their active components: Wegovy contains semaglutide, while Saxenda contains liraglutide. Despite this, both medications regulate appetite to aid weight loss. While limited studies compare them, one research indicates Wegovy may offer superior long-term weight loss compared to Saxenda.
Ozempic is another brand name for Semaglutide, which can be used for treating type 2 diabetes. Current guidance is clear that Ozempic should only be prescribed for the treatment of type 2 diabetes to protect supply for diabetes patients. It should not be prescribed solely for weight loss. The same applies for Mounjaro, a variation of Tirzepatide.
At Private Medical Clinic, our weight loss services begin with a thorough GP consultation, where we assess your goals, medical history, and lifestyle factors. Our doctors conduct a detailed review of your diet, exercise routine, and other elements that might influence your weight loss journey. Based on this evaluation, a personalised weight loss program is recommended to you.
If appropriate, your doctor will discuss the risks and benefits of various protocols, which may include weight loss injections, tailored to your specific needs and preferences. We prioritise your safety and well-being throughout the process, ensuring a comprehensive and effective approach to your weight loss goals.
WeGovy represents a significant advancement in the treatment of obesity, offering a promising option for individuals struggling to lose weight through diet and exercise alone. With its ability to promote significant weight loss and improve metabolic health, WeGovy has the potential to empower individuals on their journey to better health.
Click here to book your appointment with our weight loss clinic.
Dr. Ibrahim Mutlib (BMBS, BMedSci) is an experienced GP with specialist interests in mental health, gastrointestinal health, and respiratory medicine. A clinical leader and published author, he is passionate about innovative, patient-centred care that supports both physical and emotional wellbeing.
.avif)
